EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.7.99.4 | Adenocarcinoma |
7585460 |
Increasing development of pepsinogen-altered pyloric glands and adenocarcinoma in glandular stomach of analbuminemic rats. |
diagnostic usage therapeutic application unassigned |
1 3 0 |
1.7.99.4 | Adenocarcinoma of Lung |
33527250 |
A Novel Drug Delivery System: the Encapsulation of Naringenin in Metal-Organic Frameworks into Liposomes. |
ongoing research unassigned |
1 0 |
1.7.99.4 | Albuminuria |
22874759 |
Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats. |
causal interaction therapeutic application unassigned |
3 3 0 |
1.7.99.4 | Alzheimer Disease |
17065836 |
Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. |
causal interaction therapeutic application unassigned |
4 4 0 |
1.7.99.4 | Alzheimer Disease |
27041861 |
Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks. |
causal interaction ongoing research therapeutic application unassigned |
3 3 2 0 |
1.7.99.4 | Anemia |
6542021 |
Anemia and potassium permeability of red blood cells in analbuminemic rats. |
unassigned |
0 |
1.7.99.4 | Anemia |
26111918 |
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States. |
ongoing research unassigned |
1 0 |
1.7.99.4 | Aneurysm |
16480020 |
Serial echocardiographic assessment of neo-aortic regurgitation and root dimensions after the modified Ross procedure. |
unassigned |
0 |
1.7.99.4 | Aneurysm, Dissecting |
9170854 |
[Extended total aortic arch replacement involving the proximal descending aorta through a median sternotomy] |
diagnostic usage therapeutic application unassigned |
1 2 0 |
1.7.99.4 | Apnea |
19663122 |
Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 1 1 |